Skip to main content
GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
94.51
+6.40 (7.26%)
At close: Mar 9, 2026, 4:00 PM EDT
94.20
-0.31 (-0.33%)
After-hours: Mar 9, 2026, 7:35 PM EDT

GeneDx Holdings Revenue

In the year 2025, GeneDx Holdings had annual revenue of $427.54M with 39.97% growth. GeneDx Holdings had revenue of $120.99M in the quarter ending December 31, 2025, with 26.50% growth.

Revenue (ttm)
$427.54M
Revenue Growth
+39.97%
P/S Ratio
6.47
Revenue / Employee
$328,876
Employees
1,300
Market Cap
2.77B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025427.54M122.09M39.97%
Dec 31, 2024305.45M102.88M50.79%
Dec 31, 2023202.57M-32.13M-13.69%
Dec 31, 2022234.69M22.50M10.60%
Dec 31, 2021212.20M32.87M18.33%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
RadNet 2.04B
Sotera Health Company 1.16B
Neogen 880.32M
NeoGenomics 727.33M
OPKO Health 606.88M
Veracyte 517.15M
Twist Bioscience 391.56M
CareDx 379.81M
Revenue Rankings

WGS News

More News